
News
- Home
- >
- News
Latest news
-
11 May 2023SERB Pharmaceuticals and SFJ Pharmaceuticals announce a U.S. partnership for bentracimab, a ticagrelor reversal agentSERB has acquired exclusive US rights to the ticagrelor reversal agent bentracimab from SFJ Pharmaceuticals.
-
02 May 2023New Publication Compares Total Vials of CroFab® and Anavip® Administered to Treat US Rattlesnake EnvenomationAnalysis shows patients treated with CroFab require fewer total vials of antivenom, and fewer administrations to achieve control, than Anavip.
-
15 March 2023New economic analysis of Voraxaze® (glucarpidase) in patients with delayed methotrexate eliminationModel simulation shows cost of timely Voraxaze® use is offset by shorter hospital stays and associated with substantially improved clinical outcomes West Conshohocken, PA, 15 March 2023: BTG Pharmaceuticals, a SERB company, today announces the publication of an economic simulation assessing the value of Voraxaze® (glucarpidase) for treating adult patients in the United States who […]
News archive
Date
Title